Medical technology company Vivos Therapeutics received FDA 510(k) clearance for its daytime-nighttime device to treat obstructive sleep apnea.
Vivos Therapeutics develops treatments for dentofacial abnormalities, mild-to-moderate obstructive sleep apnea and snoring in adults.
The device expands the palate to open the airway and facilitate nasal breathing, according to a Jan. 4 news release. It is Vivos' longest standing appliance and is used most among its trained dentists. The device can also be used in conjunction with other treatment modalities.